stars 1 stars 2 stars 3

Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.

Ischemix Questions

The Ischemix annual revenue was $1 million in 2026.

David Dewahl is the President and Chief Executive Officer of Ischemix.

3 people are employed at Ischemix.

Ischemix is based in Maynard, Massachusetts.

The NAICS codes for Ischemix are [3254, 325, 32, 32541].

The SIC codes for Ischemix are [28, 283].

Top Ischemix Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users